Platelet-lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: An inverse probability weighting analysis

Toshifumi Tada*, Takashi Kumada, Atsushi Hiraoka, Kojiro Michitaka, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Kazuya Kariyama, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Shinya Fukunishi, Hideko Ohama, Kazuhito KawataShinichiro Nakamura, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Korenobu Hayama, Taeang Arai, Michitaka Imai, Kouji Joko, Yohei Koizumi, Yoichi Hiasa

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Platelet-lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: An inverse probability weighting analysis'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science